跳至主要内容
临床试验/DRKS00020252
DRKS00020252已完成未知

Clinical trial Retterspitz lotion in patients with various manifestations of injuries of the muscular, tendon and joint system

Retterspitz GmbH0 个研究点目标入组 100 人开始时间: 2019年12月11日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 85 Years(—)
性别
All

入选标准

  • Patients with acute injuries of the muscles, tendons and joint system, which are not permanently in need of therapy nature.
  • - The trauma must not be older than 48 hours.
  • - Occurrence of at least one of the following complaints:
  • - swelling
  • - hematoma

排除标准

  • - Patients with an open wound on the affected part of the body
  • - Patients with fractures, torn ligaments, surgical interventions, recurrent chronic complaints and local skin infections, which do not allow the study medication.
  • - Patients taking anticoagulation or anti-platelet drugs
  • - permanent use of painkillers
  • - Use of steroidal or non-steroidal anti-inflammatory drugs within 48 hours of the onset of injury (topically, orally or intravenously)
  • - Age <18,> 85
  • - Allergy or intolerance to one or more of the ingredients used
  • - Pregnancy and breast feeding period
  • - Inability to adequately participate in the study

研究者

发起方
Retterspitz GmbH

相似试验